Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective Multicenter Single-Arm Observational Study

NCT06689956 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06689956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06689956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: a Prospective Multicenter Single-Arm Observational Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2024
Completion date
October 31, 2029
Enrollment
212 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

figo grade 1 endometrial endometrioid adenocarcinoma, figo grade 2 endometrial endometrioid adenocarcinoma, stage ia1 endometrial cancer figo 2023, stage ia2 endometrial cancer figo 2023